Please Wait.....
Report
Middle East and Africa Tumor Ablation Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Middle East and Africa Tumor Ablation Market Report and Forecast 2024-2032
Middle East and Africa Tumor Ablation Market Size
The global tumor ablation market was valued at USD 1.9 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the rising incidence of cancer. It is expected to grow at a CAGR of 11.70% during the forecast period of 2024-2032, with the values likely to attain USD 6.3 billion by 2032.
Middle East and Africa Tumor Ablation Market Outlook
- Recent data reveals that the number of new cancer cases in Saudi Arabia is estimated to reach 60,429 by 2040 . The rising incidence of cancer is expected to directly impact the market demand.
- The market share is influenced by the increased government initiatives aimed at improving cancer care and treatment access. For instance, in August 2023 , a Memorandum of Understanding was signed in Abuja (Nigeria) to tackle the rising cancer burden and improve cancer care.
- One of the major Middle East and Africa tumor ablation market trends is the increasing introduction of advanced ablation techniques in healthcare facilities. In January 2023, Tawam Hospital in the United Arab Emirates announced that they performed a thyroid radiofrequency and microwave ablation procedure for the first time to treat a patient with a large compressive benign thyroid nodule.
Middle East and Africa Tumor Ablation Market Analysis
Tumor ablation is a technique that can destroy tumor cells with minimal damage to the surrounding tissues. The procedure involves inserting a needle or probe directly into the tumor, guided by the help of imaging techniques like ultrasound, CT, or MRI. It is increasingly utilized in treating small and localized tumors and is a promising alternative for patients who are not eligible for traditional surgery. The rising adoption of this treatment modality due to its minimally invasive nature and high precision approach is significantly contributing to the Middle East and Africa tumor ablation market growth.
In the Middle East and Africa, cancer is becoming one of the leading causes of disease burden, with patient numbers projected to sharply rise in the coming decades . Recent data reveals that the number of new cancer cases in Saudi Arabia is estimated to reach 60,429 by 2040 , indicating the need for effective interventions to treat the growing patient pool. Since tumor ablation can be used in the treatment of various types of cancers, including liver, kidney, lung, and bone cancers, the high cancer incidence is expected to directly impact the Middle East and Africa tumor ablation market demand.
One of the major market trends is the increasing introduction of advanced ablation techniques in healthcare facilities in the region due to their higher efficacy and fewer side effects. In January 2023, Tawam Hospital, part of the Abu Dhabi Health Services Company (the United Arab Emirates' largest healthcare network) announced that they used a thyroid radiofrequency and microwave ablation procedure for the first time to treat a patient with a large compressive benign thyroid nodule. Further, they shared that the patient was successfully treated with this novel procedure and was discharged after an hour. The growing recognition of tumor ablation technique as a reasonable alternative to surgery is likely to improve patient outcomes and quality of life, thereby elevating the Middle East and Africa tumor ablation market value.
The market is also influenced by the increased government initiatives aimed at improving cancer care and treatment access. For instance, in August 2023 , the Federal Ministry of Health, Federal Capital Territory Administration, the Clinton Health Access Initiative, Medicaid Cancer Foundation, and City Cancer Challenge Foundation (C/Can) signed a Memorandum of Understanding to tackle the cancer burden in Abuja (Nigeria) and improve cancer care across the region. The multi-stakeholder commitment is to facilitate the reduction of cancer incidence and mortality through sustainable cancer care solutions. Such collaborative efforts are poised to increase access to innovative cancer treatment options including tumor ablation therapy in the region, which is anticipated to boost the market share.
Middle East and Africa Tumor Ablation Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Others
Market Breakup by Application
Kidney Cancer
Liver Cancer
Lung Cancer
Bone Metastasis
Others
Market Breakup by Mode of Treatment
Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation
Others
Market Breakup by End User
Hospitals and Clinics
Specialty Centers
Others
Market Breakup by Country
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Leading Players in the Middle East and Africa Tumor Ablation Market
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Medtronic Plc
- Angiodynamics
- Mermaid Medical
- HealthTronics
- Galil Medical Inc.
- EDAP TMS S.A.
- Boston Scientific Corporation
- SonaCare Medical
- Misonix, Inc.
- NeuWave Medical, Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Middle East and Africa tumor ablation market forecast outlook for 2024-2032?
The Middle East and Africa tumor ablation market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 14.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 6.3 billion by 2032.
- What are the major factors aiding the Middle East and Africa tumor ablation market demand?
The rising incidence of cancer and advancements in tumor ablation techniques are fuelling the demand for the market.
- What are the major Middle East and Africa tumor ablation market trends?
One of the significant trends in the market is the rising introduction of advanced ablation techniques in healthcare facilities to treat cancer. In January 2023, Tawam Hospital in the United Arab Emirates announced that they performed a microwave ablation and thyroid radiofrequency procedure to treat a patient with large compressive benign thyroid nodule.
- What is the market segmentation based on the technology?
Based on the technology, the market is segmented into radiofrequency (RF) ablation, microwave ablation, cryoablation, and irreversible electroporation, among others.
- What is the market breakup by mode of treatment?
By mode of treatment, the market is divided into surgical ablation, laparoscopic ablation, and percutaneous ablation, among others.
- What are the major end users of the market?
End users of the market are hospitals, clinics and specialty centers, among others.
- What are the applications of the market?
Major applications of the market include liver cancer, lung cancer, kidney cancer, and bone metastasis, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.
- Who are the key players involved in the Middle East and Africa tumor ablation market?
The key players in the market are Medtronic Plc, AngioDynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., Boston Scientific Corporation, SonaCare Medical, Misonix, Inc., and NeuWave Medical, Inc.
Meta description
The Middle East and Africa tumor ablation market is poised for growth, driven by the expansion of the global market, which was valued at USD 1.9 billion in 2023 and is projected to grow at a CAGR of 14.2% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Middle East and Africa Tumor Ablation Market Overview
3.1 Middle East and Africa Tumor Ablation Market Historical Value (2017-2023)
3.2 Middle East and Africa Tumor Ablation Market Forecast Value (2024-2032)
4 Middle East and Africa Tumor Ablation Market Landscape*
4.1 Middle East and Africa Tumor Ablation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Middle East and Africa Tumor Ablation: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Mode of Treatment
4.2.3 Analysis by Application
5 Middle East and Africa Tumor Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Middle East and Africa Tumor Ablation Market Segmentation (2017-2032)
6.1 Middle East and Africa Tumor Ablation Market (2017-2032) by Technology
6.1.1 Market Overview
6.1.2 Radiofrequency (RF) Ablation
6.1.3 Microwave Ablation
6.1.4 Cryoablation
6.1.5 Irreversible Electroporation
6.1.6 Others
6.2 Middle East and Africa Tumor Ablation Market (2017-2032) by Mode of Treatment
6.2.1 Market Overview
6.2.2 Surgical Ablation
6.2.3 Laparoscopic Ablation
6.2.4 Percutaneous Ablation
6.2.5 Others
6.3 Middle East and Africa Tumor Ablation Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Liver Cancer
6.3.3 Lung Cancer
6.3.4 Kidney Cancer
6.3.5 Bone Metastasis
6.3.6 Others
6.4 Middle East and Africa Tumor Ablation Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospital and Clinics
6.4.3 Specialty Centers
6.4.4 Others
6.5 Middle East and Africa Tumor Ablation Market (2017-2032) by Countries
6.5.1 Market Overview
6.5.2 Saudi Arabia
6.5.3 United Arab Emirates
6.5.4 Nigeria
6.5.5 South Africa
6.5.6 Others
7 Saudi Arabia Tumor Ablation Market (2017-2032)
7.1 Saudi Arabia Tumor Ablation Market (2017-2032) by Technology
7.1.1 Market Overview
7.1.2 Radiofrequency (RF)Ablation
7.1.3 Microwave Ablation
7.1.4 Cryoablation
7.1.5 Irreversible Electroporation
7.1.6 Others
7.2 Saudi Arabia Tumor Ablation Market (2017-2032) by Mode of Treatment
7.2.1 Market Overview
7.2.2 Surgical Ablation
7.2.3 Laparoscopic Ablation
7.2.4 Percutaneous Ablation
7.2.5 Others
7.3 Saudi Arabia Tumor Ablation Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Liver Cancer
7.3.3 Lung Cancer
7.3.4 Kidney Cancer
7.3.5 Bone Metastasis
7.3.6 Others
7.4 Saudi Arabia Tumor Ablation Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospital and Clinics
7.4.3 Specialty Centers
7.4.4 Others
8 United Arab Emirates Tumor Ablation Market (2017-2032)
8.1 United Arab Emirates Tumor Ablation Market (2017-2032) by Technology
8.1.1 Market Overview
8.1.2 Radiofrequency (RF)Ablation
8.1.3 Microwave Ablation
8.1.4 Cryoablation
8.1.5 Irreversible Electroporation
8.1.6 Others
8.2 United Arab Emirates Tumor Ablation Market (2017-2032) by Mode of Treatment
8.2.1 Market Overview
8.2.2 Surgical Ablation
8.2.3 Laparoscopic Ablation
8.2.4 Percutaneous Ablation
8.2.5 Others
8.3 United Arab Emirates Tumor Ablation Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Liver Cancer
8.3.3 Lung Cancer
8.3.4 Kidney Cancer
8.3.5 Bone Metastasis
8.3.6 Others
8.4 United Arab Emirates Tumor Ablation Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospital and Clinics
8.4.3 Specialty Centers
8.4.4 Others
9 Nigeria Tumor Ablation Market (2017-2032)
9.1 Nigeria Tumor Ablation Market (2017-2032) by Technology
9.1.1 Market Overview
9.1.2 Radiofrequency (RF)Ablation
9.1.3 Microwave Ablation
9.1.4 Cryoablation
9.1.5 Irreversible Electroporation
9.1.6 Others
9.2 Nigeria Tumor Ablation Market (2017-2032) by Mode of Treatment
9.2.1 Market Overview
9.2.2 Surgical Ablation
9.2.3 Laparoscopic Ablation
9.2.4 Percutaneous Ablation
9.2.5 Others
9.3 Nigeria Tumor Ablation Market (2017-2032) by Application
9.3.1 Market Overview
9.3.2 Liver Cancer
9.3.3 Lung Cancer
9.3.4 Kidney Cancer
9.3.5 Bone Metastasis
9.3.6 Others
9.4 Nigeria Tumor Ablation Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospital and Clinics
9.4.3 Specialty Centers
9.4.4 Others
10 South Africa Tumor Ablation Market (2017-2032)
10.1 South Africa Tumor Ablation Market (2017-2032) by Technology
10.1.1 Market Overview
10.1.2 Radiofrequency (RF)Ablation
10.1.3 Microwave Ablation
10.1.4 Cryoablation
10.1.5 Irreversible Electroporation
10.1.6 Others
10.2 South Africa Tumor Ablation Market (2017-2032) by Mode of Treatment
10.2.1 Market Overview
10.2.2 Surgical Ablation
10.2.3 Laparoscopic Ablation
10.2.4 Percutaneous Ablation
10.2.5 Others
10.3 South Africa Tumor Ablation Market (2017-2032) by Application
10.3.1 Market Overview
10.3.2 Liver Cancer
10.3.3 Lung Cancer
10.3.4 Kidney Cancer
10.3.5 Bone Metastasis
10.3.6 Others
10.4 South Africa Tumor Ablation Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospital and Clinics
10.4.3 Specialty Centers
10.4.4 Others
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Medtronic Plc
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Angiodynamics
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Mermaid Medical
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 HealthTronics
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Galil Medical Inc.
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 EDAP TMS S.A.
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Boston Scientific Corporation
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 SonaCare Medical
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Misonix, Inc.
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 Neuwave Medical, Inc.
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Middle East and Africa Tumor Ablation Market - Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security